Ranbaxy Wins Nod for Generic Diovan

Ranbaxy won FDA approval to produce a long-delayed generic version of Novartis's blockbuster blood-pressure drug Diovan, improving the Indian company's prospects after years of regulatory problems.



from WSJ.com: US Business http://ift.tt/1qNj3N1

via IFTTT